2nd Quarter - Report
ADVANCED STRATEGIES for COVIDIEN, INC.
Firm
Client
Income
$110,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
S. 232 Medical Device Access & Innovation Protection Act H.R. 523 Protection of Medical innovation International Tax Issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN SASSO | N.A. |
Health Issues HCR
Food and Drug Administration Processes
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN SASSO | N.A. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.